Company Overview of Premune AB
Premune AB, an animal health company, develops treatments for allergies, inflammatory bowel diseases, and other immune disorders in pets worldwide. Its developments are targeting problem areas in veterinary medicine. The company was founded in 2009 and is based in Stockholm, Sweden.
Kungsgatan 3 vån 4
Stockholm, 111 43
Founded in 2009
46 7 60 26 52 69
Key Executives for Premune AB
Similar Private Companies By Industry
|Abera Bioscience AB||Europe|
|Adenovir Pharma AB||Europe|
|Affibody Medical AB (publ)||Europe|
|Akinion Pharmaceuticals AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Premune AB, please visit www.premune.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.